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Sleep disorders are associated with cognitive impairment. Selective rapid eye
movement sleep (REMS) deprivation (REMSD) alters several physiological processes
and behaviors. By employing NGS platform we carried out transcriptomic analysis in
brain samples of control rats and those exposed to REMSD. The expression of genes
involved in chromatin assembly, methylation, learning, memory, regulation of synaptic
transmission, neuronal plasticity and neurohypophysial hormone synthesis were altered.
Increased transcription of BMP4, DBH and ATP1B2 genes after REMSD supports our
earlier findings and hypothesis. Alteration in the transcripts encoding histone subtypes
and important players in chromatin remodeling was observed. The mRNAs which
transcribe neurotransmitters such as OXT, AVP, PMCH and LNPEP and two small
non-coding RNAs, namely RMRP and BC1 were down regulated. At least some of
these changes are likely to regulate REMS and may participate in the consequences
of REMS loss. Thus, the findings of this study have identified key epigenetic regulators
and neuronal plasticity genes associated to REMS and its loss. This analysis provides
a background and opens up avenues for unraveling their specific roles in the complex
behavioral network particularly in relation to sustained REMS-loss associated changes.
Keywords: REM sleep deprivation, transcriptome, brain excitability, epigenetics, histone code, memory
consolidation, neurotransmitter
INTRODUCTION
Sleep is amongst the most conserved instinctive behaviors. It has been classified into rapid eye
movement sleep (REMS) and non-REMS. Disturbance including restriction, fragmentation or loss
of REMS is associated with several acute as well as chronic psycho-somatic-behavioral dysfunctions
(Van Dongen et al., 2003), cognitive and memory dysfunctions (Walker and Stickgold, 2014),
neurodegenerative diseases, hypertension, diabetes, mood disorder, altered neuronal growth,
development and excitability (Mallick and Singh, 2011). All these patho-physio-behavioral
modulations can take place due to changes in the levels of one or more biomolecules or its
metabolites or sometimes due to synthesis of new molecule(s). Although the precise function(s) of
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REMS and its detailed mechanism of regulation is not yet
known, many hypotheses have been put forward about its role
in maintaining several normal physiological processes (Stickgold
et al., 2001). As a unified hypothesis it has recently been proposed
that REMS serves house-keeping functions by maintaining
brain neuronal excitability (Mallick and Singh, 2011). Its
functions have been investigated by evaluating the effects of
rapid eye movement sleep deprivation (REMSD) on several
physiological parameters. However, regardless of the advances
in our knowledge on regulation and function of REMS (Mallick
et al., 2011), there are serious lacunae in our understanding
of the molecular mechanism underlying REMS-loss associated
alteration of physiological conditions and symptoms, particularly
its sustained long-term effects (Mehta et al., 2015).
Rapid eye movement sleep deprivation affects several
hormones, metabolites (Spiegel et al., 1999; Zalfa et al.,
2006), interleukins, enzymes, neuronal structural proteins and
induces apoptosis (Biswas et al., 2006) in the brain; however,
transcriptional regulation of these processes is unknown.
In order to understand the long term effects of REMSD,
including expression of symptoms due to chronic REMS-
loss and associated disorders, it will be useful to examine
the modulation of bio-molecules which is likely to occur
as a consequence of altered gene expression. Microarray
based analysis of brain samples upon total sleep loss, which
includes loss of both REMS as well as non-REMS, has been
reported (Cirelli et al., 2004; Vecsey et al., 2012). Short-
term (8 h) total sleep loss affected transcription of about 5%
of cortical genes (Cirelli et al., 2004), while long-term total
sleep deprivation significantly induced expression of transcripts
coding for many proteins including those related to synaptic
plasticity, memory consolidation, membrane trafficking (Tononi
and Cirelli, 2014), mitochondrial proteins, heat-shock proteins
and synaptic potentiation (Ravassard et al., 2009). In this study,
we have employed next generation sequencing (NGS) technology
to analyze the brain transcriptome (RNA seq) of control and
selective REMS deprived rats. Our findings provide insight into
the possible molecular-genetic mechanisms in the brain that are
closely associated with pathological conditions due to REMS loss
in particular and sleep disorder in general.
MATERIALS AND METHODS
Animal Care and Rapid Eye Movement
Sleep Deprivation
The experiments were carried out on male Wistar rats
(225–250 gm) maintained at 24 + 2◦C and 12:12 h light:dark
cycle with ad libitum free access to food and water. Experimental
procedures were approved by the Institutional Animal Ethical
Committees of the Savitribai Phule Pune University, Pune
and Jawaharlal Nehru University, New Delhi in accordance
with the national guidelines provided by the Committee for
the Purpose of Control and Supervision on Experiments on
Animals (CPCSEA). Home cage normal rats were taken as free
moving control. Standard protocol was followed for REMSD
by the flower pot method (Gulyani and Mallick, 1993, 1995;
McDermott et al., 2003). In brief, for REMSD the experimental
rat was maintained on a small platform (6.5 cm diameter)
surrounded by water for 4 days (96 h) (Gulyani and Mallick,
1993; Amar and Mallick, 2015). Rats were deprived of REMS
for 4 days as we have shown that the period is optimum for
inducing change in many biomolecules (Mallick and Singh,
2011). The rats become aggressive and irritated, humans also
become irritated after sleep-loss. To rule out the effects due
to non-specific factors, another control rat was maintained
on larger platform of 13 cm diameter surrounded by water.
These large platform control rats were maintained under similar
conditions as that of the experimental (REMSD) rats except
for the platform size. They experienced non-REMS as well as
REMS comparable to free moving control. Recovery control rats
were deprived of REMS for 4 days (96 h) and then allowed
to recover from REMS loss for 3 days in home cages. In yet
another group, the rats were REMS deprived for 4 days and
while deprivation was continuing, on the third and fourth day
of deprivation the rats received (0.5 ml of 4 mg/kg i.p.) alpha1
adrenoceptor (AR) antagonist, Prazosin (PRZ) dissolved in 20%
N,N-dimethylacetamide (N,N-DA). Prazosin was dissolved in a
very small (0.1 ml) quantity of N,N-DA and made to 0.5 ml
with saline for i.p. injection. In our earlier studies, the same
concentration (20%) of N,N-DA as vehicle was ineffective on
sleep-waking as well as thermoregulation when injected (0.4 or
0.2 µl) locally directly into specific sites in the brain (Mallick and
Alam, 1992; Mallick and Joseph, 1998; Pal and Mallick, 2006)
or injected (0.5 ml) i.p. (Jaiswal and Mallick, 2009); therefore,
we did not consider necessary to carry out separate N,N-DA
treated control group(s). The Prazosin blocks REMSD-associated
noradrenaline (NA)-induced increase in Na–K ATPase activity
(Gulyani and Mallick, 1995). After completion of REMSD, the
rats were euthanized, decapitated and the brains taken out for
further processing.
Synaptosomal Sodium Potassium
ATPase Enzyme Assay
Synaptosome Preparation
The synaptosomes were prepared from all the control and
experimental (REMSD, large platform control, free moving
control, recovery control and Prazosin treated) rat brains
(n = 4 rats per group) as described earlier (Gulyani and
Mallick, 1995). Briefly, the brains were quickly removed and
homogenized in 10 ml chilled buffer containing 12 mM Tris,
0.32 M sucrose and 1 mM EDTA, pH 7.4. The homogenate
was centrifuged at 6000 rpm (3000 × g) for 5 min and
then 5 ml of the supernatant was centrifuged at 12,000 rpm
(11000 × g) for 20 min. The pellet was re-suspended in 1 ml
of homogenizing buffer, which was then loaded on to 1.2 M
and 0.8 M sucrose gradient and ultracentrifuged in a swing-
out rotor for 2 h at 25,000 rpm (105,000 × g). At the end
of ultracentrifugation the synaptosomes were obtained as a
band at the interface of the sucrose gradients. The band of
synaptosomes was retrieved, diluted with 2 ml homogenizing
buffer and centrifuged for 45 min at 25,000 rpm (105,000 × g)
to obtain the synaptosomes as a pellet. All the steps were carried
out at 4◦C.
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Sodium Potassium ATPase Activity
The ouabain sensitive Na–K ATPase activity was estimated
following the method of Akagawa and Tsukada with minor
modification as reported earlier (Gulyani and Mallick, 1995). In
brief, 30 µg of the synaptosomes were incubated at 37◦C for
15 min in the reaction buffer containing 100 mM NaCl, 20 mM
KCl, 5 mM MgCl2, 3 mM ATP and 50 mM Tris, pH 7.4. Ouabain
(1 mM) was used as Na–K ATPase specific blocker and ATP
was used as the substrate. The liberated inorganic phosphate (Pi)
was estimated spectrophotometrically using Fiske and Subbarow
(1925) method. The Na–K ATPase activity was calculated as the
difference of activities in the sample in presence and absence of
ouabain and expressed as µmoles of Pi released per mg protein
per hour.
RNA Extraction and Sample Preparation
For the extraction of total RNA, the REMSD and free moving
control whole brains were individually homogenized in
TRIzol (Life Technologies, USA) using mortar and pestle
according to the protocol provided by the manufacturer.
Total RNA was treated with TURBO DNA free kit (Life
Technologies, USA) to remove DNA contamination.
Qubit RNA BR Assay Kit (Life Technologies, USA) was
used for quantitation of RNA concentration and Agilent
Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA) was used
for quality assessment of each sample. All samples with RNA
integrity number (RIN) above 7.4 were taken for further
analysis.
Construction of RNA-seq Libraries, RNA
Sequencing, and Data Generation
The mRNA sample preparation was done by using Truseq
mRNA sample preparation kit (Illumina, San Diego, CA, USA)
as per manufacturer’s instructions. RNA was treated with Ribo-
Zero magnetic kit (Epicentre, USA) for rRNA depletion in
accordance with manufacture’s protocol. The poly (A) RNA was
captured from rRNA depleted RNA using poly-dT magnetic
beads and was chemically fragmented to a size around 200–
300 bp. These RNA fragments were used for first and second
strand cDNA synthesis. Single (A) base overhang was added
to the blunt ends to enable adapter ligation with the (T) base
overhangs. These product fragments were purified and used
for enrichment by using adapter specific PCR. The libraries
were amplified using c-Bot (Illumina, San Diego, CA, USA)
to produce clusters. By using Agilent Bioanalyzer quality and
size distribution of the cDNA library was checked. Fragments
size for the cDNA library were between 200 and 500 bp, with
a peak at ∼300 bp. Qubit 2.0 Fluorometer (Life Technologies,
Foster City, CA, USA) were used for the quantification of
libraries. The cDNA library was sequenced by 100 × 2 paired
end on Illumina Hiseq 2000 sequencer (Illumina, San Diego, CA,
USA).
Read Mapping and Expression Analysis
Based on the quality of sequence reads, they were trimmed
where necessary to retain only high quality sequence for
further analysis. From the trimmed paired-end reads the
unwanted sequences, e.g., the ribosomal RNAs, transfer RNAs,
mitochondrial genome sequence, adapter sequences and others
were considered as contamination and removed using bowtie2
(version 2.1.0), in-house Perl scripts and picard tools (version
1.85). The paired end files so generated were trimmed using
SolexaQA with Phred quality score of 30. Adapter trimming and
length sorting were performed using trimmomatic PE software
package. The pre-processed reads were aligned to the reference
Rattus norvegicus genome and gene model downloaded from
UCSC database (ASSEMBLY NAME: Rnor_6.0; ASSEMBLY
DATE: 1 July 2014). The alignment was performed using
TopHat program (version 2.0.8) with default parameters. We
only used uniquely mapped reads for further analysis. The
alignments were processed and the expression levels were
quantitated using Cuﬄinks based on the gene loci annotations
and GENCODE transcripts (Rajpathak et al., 2014). The reads
mapping for the corresponding gene annotations were calculated
as fragments per kilo base of transcript per million mapped reads
(FPKM).
In order to identify differentially expressed genes (DEGs),
RNA sequencing data was analyzed using Cuffdiff with a
P-value< 0.05 in log-transformed expression value (log2 FPKM).
All genes with significant expression change (P-value < 0.05)
were further analyzed (Yu et al., 2014). Also, DEGs with more
stringent false discovery rate (FDR) with the q-value set at 0.05
were analyzed separately.
Functional Analysis of Differentially
Expressed Genes
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) was used to identify significantly enriched
Gene Ontology categories and for functional annotations of
DEGs. Functional annotation clustering was carried out for
ranking enriched term groups with enrichment score (ES) ≥ 1.3
and P < 0.05. Groups with higher ES have been suggested to be
more relevant to the study.
Quantitative Real Time PCR (qRT-PCR)
Assay
Validation of RNA-Seq data was carried out by qRT-PCR of
13 DEGs. RNA was isolated separately from the REMSD, large
platform control, free moving control, recovery control and
Prazosin treated rat brains (n = 5 rats per group) using
TRIzol as described above. The cDNA was prepared using
1 µg of total input RNA from all samples using Superscript III
(Invitrogen, USA) according to the manufacturer’s instruction.
qRT- PCR was carried out using SYBR Green master mix
(TAKARA, USA) for detection in StepOnePlus Real Time-
PCR system (ABI, USA). We evaluated relative expression of
each gene against the expression of GAPDH gene as internal
control in respective brain sample. The primer sequences have
been shown in Table 1. Differences in gene expression were
statistically evaluated using one-way analysis of variance with
Neuman–Keul’s test; at least P < 0.05 was taken as statistically
significant.
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TABLE 1 | Lists of primers used in gene expression analyses by real-time qPCR.
Gene Forward primer (5′–3′) Reverse primer (5′–3′) Acc number
OXT GCTGCGCTAGACCTGGATATG GAAGCAGCCCAGCTCGT NM_012996
GAPDH GGGAAACCCATCACCATCTT CCAGTAGACTCCACGACATACT NM_017008.4
AVP CGCCATGATGCTCAACACTA CTTGGGCAGTTCTGGAAGTAG NM_016992.2
LNPEP TTAGCCTACATCCAAACCTAACC GGAGAATGATGTCCCGTGTATC NM_001113403.1
RMRP CTGAGTGCTCGTCACTCTCT GCTCTCTGGGAACTCACCT NR_002703.1
HIST2H4 GCAGAGGAAAGGGTGGTAAG TGGATGTTATCCCGCAAGAC NM_001123469.1
GRIN2B GCTCAGATCCTCGACTTCATTT ACTCATCCTTATCCGCCATTATC NM_012574.1
HCRT GCATCCTCACTCTGGGAAAG GGTTACCGTTGGCCTGAA NM_013179.2
PMCH CAGGAACGTAGAAGACGACATAG TCCAGAGAAGGAGCAACAAC NM_012625.1
ATP1B2 TGGTTGAGGAGTGGAAGGA CGAGGTAGAAGAGGAGGATGAA NM_012507.3
DBH GGTGAACAGAGACAACCACTAC GCACGAAGTGATGAGGACAT NM_013158.2
NPAS4 CCTAATCTACCTGGGCTTTGAG GGCGGTAGTGTTGAGAAGAA NM_153626.1
EGR1 GCTCACTCCACTATCCACTATC GTTGGGACTGGTAGGTGTTATT NM_012551.2
SYT2 CTGACTGAAGGAGAAGGAGAAG CTGGTTGGCTTGGAAATCATAG NM_012665.1
OXT – oxytocin; GAPDH – glyceraldehyde 3-phosphate dehydrogenase; AVP – arginine vasopressin; LNPEP – leucyl/cystinyl aminopeptidase; RMRP – RNA component
of mitochondrial RNA processing endoribonuclease; HIST2H4 – histone cluster 2, H4; GRIN2B – glutamate receptor, ionotropic, N-methyl D-aspartate 2B; HCRT –
hypocretin (orexin); PMCH – pro-melanin concentrating hormone; ATP1B2 – Na–K ATPase beta-2 polypeptide; DBH – dopamine beta-hydroxylase; NPAS4 – neuronal
PAS domain protein 4; EGR1 – early growth response 1 and SYT2 – synaptotagmin 2.
RESULTS
Changes in Na–K ATPase Activity after
REMSD
It has been consistently shown that the synaptosomal Na–K
ATPase activity is increased after REMSD in rats. We have
estimated Na–K ATPase activity in control and REMS deprived
rat brains as circumstantial and associated confirmation of
REMSD. Indeed we observed that the enzyme activity increased
significantly upon REMSD as compared to free moving control
(P < 0.001) and large platform control (P < 0.001). The activity
returned to the baseline level upon 3 days of recovery sleep
after REMSD or after Prazosin treatment to the REMS deprived
rats (Figure 1A). Transcriptome analysis showed that ATP1B2
transcripts (responsible for synthesis of Na–K ATPase) were
significantly up-regulated (P= 0.019) upon REMSD (Figure 1B).
This was further confirmed by qRT-PCR where a significant
(P < 0.001) increase in the level of mRNA of ATP1B2 was
observed in REMSD rat brains (Figure 1C) as compared with
free moving control, large platform control, recovery control and
Prazosin treated rats. The ATP1B2 transcripts were also elevated
in the large platform control rat brains as compared to that
of the free moving control (P = 0.007) and Prazosin treated
(P = 0.005) rats; however, it was comparable to recovery control
rats.
Rat Transcriptome Data Generation and
Analysis
Poly-A tailed RNA was obtained from the REMSD and free
moving control rat brains. RNA sequence reads were generated
using paired-end sequencing method. A total of 31.34 and
59.31 million raw sequence reads from REMSD and free
moving control rat brains, respectively, were generated using
Illumina Hiseq 2000 (Illumina, USA). After quality filtering
(≥30 Phred score) about 90.6% and 88.4% of the reads from
the REMSD and the free moving control, were used for
analysis. Out of the analyzed reads, 91% of the sequence reads
were mapped back to the reference Rattus norvegicus genome
(ASSEMBLY NAME: Rnor_6.0; ASSEMBLY DATE: 1 July 2014).
RNA sequencing raw data was generated and the results of
alignment have been summarized in Table 2. The FPKM values
of each gene were calculated using Cuﬄink and raw data
have been submitted to NCBI SRA database with accession
number SRR3270972 (free moving control) and SRR3318878
(REMSD).
Differentially Expressed Genes (DEGs)
and Functional Analysis
Cuffdiff analysis and quantile normalization showed that
216 genes were (P < 0.05) differentially expressed; 136 were
up-regulated, while 80 were down-regulated after REMSD
as shown in the heat-map (Figure 2). Functional analysis
of the gene-sets showing differential expression (P < 0.05)
revealed enrichment of several functional categories as
shown in Supplementary Tables S1, S2. The gene ontology
of these clustered categories represents genes involved in
chromatin assembly (ES = 3.25; P < 0.0000046), regulation
of synaptic transmission (ES = 1.49; P < 0.0032), methylation
(ES = 3.25; P < 0.000017), behavior (ES = 1.49; P < 0.000051),
regulation of homeostatic processes (ES = 2.30; P < 0.0008),
transcription regulation (ES = 2.03; P < 0.00013), regulation of
neurological system process (ES = 1.49; P < 0.0006), regulation
of synaptic plasticity (ES = 1.49; P < 0.03), neuropeptide
hormones (ES = 1.49; P < 0.001) and regulation of response
to external stimulus (ES = 1.3; P < 0.006). It was interesting
to note that transcription of 28 transcription factors was
significantly up-regulated after REMSD (Supplementary
Table S3). This suggests that REMSD sets a stage for a large
scale transcriptional modulation mediated through networks
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FIGURE 1 | Na–K ATPase activity and expression: (A) Na–K ATPase
activity in synaptosomes prepared from rat brains (n = 4 rats per groups).
(B) RNA seq data showing significant up-regulation of ATP1B2 transcripts
upon REMSD (P < 0.019) as compared to Free Mov rat brain. (C) These
results were confirmed by qRT-PCR (n = 5 rats per groups). Statistical
analyses were performed using one-way ANOVA followed by Newman–Keuls
multiple comparison tests. Data are expressed as the mean ± SEM
(∗∗P < 0.005, ∗∗∗P < 0.001). REMSD – rapid eye movement sleep
deprivation; Free Mov – free moving control; Lrg Plat – large platform control;
Rec Ctrl – recovery control; and PRZ treated – Prazosin treated group.
of these transcription factors. Some of these transcription
factors namely, BMP4, NPAS4, EGR1, EGR4, FOSB, NCOR2,
PPARD and FOXO3 (Cirelli et al., 2004, 2006; Millstein et al.,
2011; Elliott et al., 2014), were highly expressed upon total
sleep deprivation (which includes loss of REMS as well as
non-REMS). This suggests that although REMSD has several
specific effects, it shares some common pathways with total
sleep loss. Many genes encoding histone variants, which
are involved in chromatin and nuclear assembly showed
significant down regulation upon REMSD. Thus, it is tempting
to speculate that the histone code and consequently the
chromatin remodeling machinery are influenced by REMSD.
The neuronal regulatory genes, namely, dopamine beta-
hydroxylase (DBH) (P = 0.0009), Na–K ATPase beta-2 subunit
(ATP1B2) (P = 0.019), synaptotagmin-2 (SYT2) (P = 0.011)
and neurosecretory protein VGF (P = 0.01) showed increased
expression after REMSD (Supplementary Table S2). Highlighting
the altered regulatory cascades, the excitatory neuropeptide
hypocretin (HCRT) (P = 0.0008) and synaptic plasticity related
GRIN2B (P = 0.0006) genes were also down regulated upon
REMSD.
After stringent analysis, a total of 11 genes were significantly
(q-value < 0.05) down-regulated upon REMSD as shown in
the volcano-plot Figure 3 and Supplementary Table S4. These
include oxytocin (OXT), pro-melanin-concentrating hormone
(PMCH), leucyl/cystinyl aminopeptidase (LNPEP), arginine –
vasopressin (AVP), hemoglobin subunit beta-1 (HBB), one
long non-coding RNA–RNA component of mitochondrial RNA
processing endo-ribonuclease (RMRP), one small non-coding
RNA brain cytoplasmic RNA1 (BC1) and four variants of
histone proteins. These gene sets were enriched under the
following functional categories viz. behavior, including feeding,
aggressiveness, learning and memory, nucleosome assembly,
regulation of transmission of nerve impulse, chromatin assembly
or disassembly and synaptic plasticity. Gene ontology of these
DEGs is given in Supplementary Table S5 and gene enrichment
is depicted in a pie chart (Figure 4).
Validation of RNA Sequencing Data by
Quantitative Real Time-PCR (qRT-PCR)
In order to validate the RNA sequencing data, 13 genes viz. OXT,
LNPEP, HIST2H4, AVP, HCRT, RMRP, ATP1B2, GRIN2B, DBH,
NPAS4, EGR1, SYT2 and PMCH involved in the regulation of
factors controlling sleep, social memory and neuronal excitability
were chosen for qRT-PCR analysis. Additional controls such as
large platform control, recovery control and Prazosin treated rats
were also included in our analysis. We observed that expression
of mRNA of OXT, LNPEP, HIST2H4, AVP, HCRT, RMRP and
PMCH genes significantly (P < 0.001) decreased after REMSD
as compared to free moving control, large platform control,
recovery control and Prazosin treated samples. The ATP1B2,
DBH, NPAS4, EGR1 and SYT2 gene expression was significantly
increased after REMSD as compared with other controls. Real
time data and RNA sequencing data (log 10 FPKM values) of the
selected genes have been summarized in Figure 5.
DISCUSSION
Rapid eye movement sleep is an essential component of
sleep in mammals and in many vertebrates and its regulation
is very complex. Throughout life an individual spends a
significant proportion of time in REMS. It has been implicated
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TABLE 2 | Sequencing raw data generated and data analysis results.
Sample name Raw reads (paired end) Base (Gb) GC (%) % of data ≥ Q30 Raw read length (bp)
A) Fastq File Summary:
REMSD 15,673,204 3.1 49.67 90.6 100 x 2
Free Mov 29,657,987 5.9 48.8 88.4 100 x 2
B) Read alignment summary:
Sample name Total reads Aligned read count Aligned %
REMSD 31,346,408 25,591,827 91.36
Free Mov 59,315,974 45,404,529 91.68
(A) Fastq file summary after RNA seq data generation, about 90% data passes Phred score ≥ Q30 and (B) read alignment results after data analysis, around 91% of data
aligned to Rattus norvegicus genome for both REMSD and Free moving control (Free Mov).
FIGURE 2 | Heat Map of differentially expressed genes (DEGs). Clustered heat Map depicting DEGs after 96 h of selective REMSD as compared with Free Mov
control. A total of 216 genes showing significantly altered gene expression (P < 0.05); out of which 80 genes were up-regulated and 136 genes were
down-regulated upon REMSD.
in cognitive and higher brain functions of higher mammals
including humans. Although it is expressed throughout life
and its quantity is reduced with aging, it is never absent in
life. The strategic importance of REMS in maintaining physio-
behavioral processes may be highlighted by the fact that its
loss has been shown to affect brain neurotransmitter levels and
molecules regulating their synthesis and metabolism, leading
to immediate as well as sustained patho-physio-behavioral
changes (Kushida, 2004). Many disorders lead to disturbances
in REMS, including its reduction and fragmentation, which may
lead to many psycho-somatic-behavioral dysfunctions, some of
which are chronic in nature. Therefore, directly or indirectly,
REMSD is likely to alter the gene regulation that may be the
underlying cause for the REMSD associated complex patho-
physiological changes, particularly those associated to sustained
changes. Although microarray analysis has been employed in
earlier studies where evaluation was done after short- and
long-term total sleep deprivation (which includes REMSD) of
the subjects (Cirelli and Tononi, 2000; Maret et al., 2007;
Massart et al., 2014), there was no report about transcriptome
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FIGURE 3 | Volcano plot of DEGs. Volcano plot showing DEGs (q < 0.05), out of which 11 genes down regulated upon REMSD as compared to free moving
control (FMC).
modulation after selective REMSD in the brain. In order to
examine the changes in the gene expression pattern, we have
employed NGS based transcriptome analysis of rat brain after
96 h of selective REMSD in comparison with free moving
control. The expression of 216 genes involved in several
physiological processes were significantly altered (Figure 2).
This suggests that REMSD is a strong modulator of the
transcriptome in the brain. Functional analysis of DEGs revealed
that the expression of genes related to neurotransmission,
synaptic plasticity, transcription factors, epigenetic regulators
like histone proteins and non-coding RNA were significantly
affected.
Neuropeptides are Down Regulated after
REMSD
We observed that REMSD significantly down-regulated
expression of genes encoding hypothalamic neuropeptides like
AVP, LNPEP, OXT, HCRT and PMCH in the rat brain and
most of these have been shown to modulate synaptic strength
(Adamantidis and de Lecea, 2009; Beets et al., 2012; Yang et al.,
2013), neurobehaviors and sleep-wakefulness (Carter et al., 2012).
OXT and AVP modulate social behavioral skills (Ebstein et al.,
2009) and memory consolidation. LNPEP, a zinc-dependent
aminopeptidase that cleaves vasopressin, oxytocin and other
peptide hormones, was down-regulated upon REMSD. LNPEP is
also involved in the final step of conversion of angiotensinogen
to angiotensin IV and enhance acquisition, consolidation and
recall in animal models of learning and memory (Stragier
et al., 2008); it may have bearing with REMSD-associated
hypertension. OXT is associated with cognition, tolerance,
adaptation as well as complex sexual and maternal behaviors
(Argiolas and Gessa, 1991) and its level elevated during active
REMS (Blagrove et al., 2012). Interestingly, while dysregulated
OXT levels are implicated in autism-spectrum disorders and
OXT supplementation may help patients with autism; children
with autism also show reduced REMS (Tanguay et al., 1976).
Hypocretin gene encodes for hypocretin (orexin), which
regulates REMS, feeding behavior, metabolism (Martin-Fardon
and Boutrel, 2012), learning and memory (Yang et al., 2013) and
there is differential expression of HCRT upon REMSD in discrete
brain areas (Mehta et al., 2015). HCRT dysregulation leads to
pathological conditions like narcolepsy (Chemelli et al., 1999)
and sleep apnea (Nakamura et al., 2007). PMCH gene expression
was reduced after 96 h of REMSD. The highly conserved
MCH system regulates multiple brain functions in the animal
kingdom. MCH-ergic neurons in the lateral hypothalamus have
been implicated in the regulation of sleep-wake behavior, energy
homeostasis and food intake (Modirrousta et al., 2005; Luppi
et al., 2013). The MCH-ergic neurons are active during sleep and
positively regulate REMS (Pelluru et al., 2013) and MCH-ergic
receptors are present in high density in sleep regulating areas
(Jego et al., 2013). MCH knockout mice have reduced REMS
(Willie et al., 2008) and genetically inactivated MCHR1 exhibited
altered sleep homeostasis (Monti et al., 2013). MCH also plays an
important role in learning and memory by regulating neuronal
synaptic plasticity (Rao et al., 2008). We have observed that
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FIGURE 4 | Gene ontology of DEGs. Gene ontology of DEGs shows association with biological processes, molecular functions and cellular component like
learning or memory, nucleosome assembly, behavior, synaptic transmission, feeding behavior, synaptic plasticity, aggressive behavior and transmission of nerve
impulse etc. upon REMSD.
GRIN2B gene, which codes for ionotropic glutamate receptor
subunit NR2B, is down-regulated in the brain after REMSD.
GRIN2B has been reported to be modulated in localized brain
areas after total sleep deprivation (Cirelli et al., 2006; Xie
et al., 2015). GRIN2B and other N-methyl-D-aspartate receptor
(NMDAR) are important molecular determinants of synaptic
excitability and modulate synaptic plasticity and learning ability
(Riedel et al., 2003). On the other hand, sleep deprivation affects
hippocampus dependent learning and memory (Graves et al.,
2003). Since REMSD affects cognitive ability, it is interesting to
speculate that these neuropeptides and their receptors may be
major players in regulation of cognitive functions, particularly for
inducing chronic effects.
Differentially Expressed Non-coding
RNAs
It was seen that expression of one lncRNA viz. RMRP and
one small RNA viz. BC1 were down regulated upon REMSD
(Figure 5). RMRP possesses RNA-dependent RNA polymerase
activity that produces double-stranded RNAs, which may be
processed into small interfering RNA (Rogler et al., 2014).
Brain cytoplasmic RNA (BC1) acts as a part of ribonucleo-
complex and is involved in the regulation of neuronal protein
synthesis (Zalfa et al., 2006). BC1 has the ability to be transported
throughout the axons and dendrites (Muslimov et al., 2002)
and reduces initiation of mRNA translation (Wang et al., 2002).
BC1 regulates translation of Dopamine D2 receptor (DRD2)
(Centonze et al., 2007). DRD2 stimulation in mice lacking BC1
seems to alter expression of a small non-coding dendritically
localized RNA that is supposed to play a role in DRD2 mRNA
translation. Repression of BC1 leads to dysregulation of plasticity
and neuronal hyper-excitability (Merlin, 2010). Decreased BC1
expression after REMSD, as observed in this study may provide
a link to the increased neuronal excitability (Mallick and Singh,
2011) and reduced cognitive function (Walker and Stickgold,
2014) after REMSD.
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FIGURE 5 | Validation of rat brain RNA seq data using different controls. Some genes were selected for validation of RNA seq data by qRT-PCR. (A) RNA
sequencing results (log 10 FPKM values) showing DEGs involved in sleep and neuronal regulation like OXT, RMRP, LNPEP, AVP, HIST2H4, GRIN2B, PMCH and
HCRT were down regulated upon REMSD. Other set of genes up regulated upon REMSD, which includes DBH, NPAS4, EGR1 and SYT2. For validation of these
RNA seq results, we have included other additional controls like large platform control (Lrg Plat), recovery control (Rec Ctrl) and Prazosin treatment group (PRZ
treated). (B–M) Shows qRT-PCR results for above genes in free moving control (Free Mov), large platform control (Lrg Ctrl), REMSD, recovery control (Rec Ctrl),
Prazosin treatment group (PRZ treated) (n = 5 per group). Statistical analyses were performed using one-way ANOVA followed by Newman–Keuls multiple
comparison tests. Data are expressed as the mean ± SEM (∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.001).
Expression of Histone Coding Genes is
Altered after REMSD
Histone code is a major contributor to chromatin remodeling
and epigenetic reprogramming. The transcriptome analysis
in the present study revealed that upon REMSD a major
histone signature gets affected; 12 histone coding genes were
down-regulated. These histones are involved in chromatin
structure, nucleosome assembly, chromosome condensation,
transcriptional regulation and cell differentiation. Depletion
of these histone variants leads to de-repression of several gene
transcription (Gossett and Lieb, 2012). The histone variants
viz. HIST1H4M, HIST1H2BL, HIST1H4B, HIST1H2AIL,
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HIST2H3C2, HIST3H2A, HIST3H2BB, HIST1H2AN and
HIST2H4 have been suggested to be involved in systemic
lupus erythematosus disease (Cozzani et al., 2014). Also,
total sleep deprivation, which includes REMS loss, has been
reported to predispose mice to autoimmune disease (Palma
et al., 2006). Thus, the findings of this study offer possible
explanation underlying REMS-loss associated molecular-genetic
and epigenetic mechanism(s) of action. Earlier findings could
be due to complete or partial loss of REMS. Whether exclusive
non-REMS loss may affect part of the changes needs further study
by designing innovative experimental approach. Additionally,
the importance of this study is that it shows linkages between
autoimmune diseases and REMS-loss, in particular.
Genes Encoding Transcription Factors
are Upregulated
We have observed increased expression of some transcription
factors after REMSD. Over expression of bone morphogenetic
protein 4 (BMP4), a transcription factor, has been shown to
lead to increased synthesis of SYT2 and tyrosine hydroxylase
(TH) in noradrenergic neurons (Patzke et al., 2001). TH is
the rate limiting enzyme for the synthesis of NA, which is
elevated upon REMSD (Basheer et al., 1998). REMSD led to
increased expression of DBH gene that convert dopamine to
NA in the NA synthesis pathway and synaptic fusion promoting
protein, SYT2 after REMSD. SYT2 help in vesicle fusion for
the release of neurotransmitter including NA in the synaptic
cleft (Papke et al., 2012). Thus, elevated BMP4, DBH and
SYT2 show a link to the sustained increased release of NA
upon REMSD (Mallick and Singh, 2011). We have earlier
reported elevated levels of phosphorylated synapsin and Na–
K ATPase activity upon REMSD (Singh et al., 2012). These
findings support our contention that REMSD induced elevated
NA increases Na–K ATPase activity (Gulyani and Mallick,
1995) and provide explanation for sustained alteration of brain
excitability after REMSD. Thus, the findings offer molecular-
genetics level explanation and support our hypothesis that one
of the fundamental functions of REMS is to maintain brain
excitability and REMS maintains house-keeping function of the
brain (Mallick and Singh, 2011).
Another activity dependent transcription factor, Neuronal
PAS Domain Protein 4 (NPAS4), was up-regulated upon REMSD.
NPAS4 regulates the quantity and function of inhibitory synapses
by causing redistribution of these synapses in the mouse
hippocampus. Brain derived neurotrophic factor (BDNF), the
target gene of NPAS4 coordinates this redistribution of inhibitory
synapses on the cell bodies and apical dendrites (Bloodgood et al.,
2013). We also observed significantly increased expression of
neurosecretory VGF gene upon REMSD. VGF gene expression
is induced by increased BDNF expression (Alder et al., 2003).
Earlier, it has been shown that both VGF (Cirelli et al., 2006)
and BDNF (Cirelli et al., 2004) gene expression were up-
regulated after total sleep loss and VGF knockout mice showed
impairment of spatial memory (Lin et al., 2015). The state
dependent plasticity related genes like early growth response
protein 1 (EGR1) (zif-268), nerve growth factor-induced protein
C (EGR4) and immediate early gene FOSB show significantly
increased expression upon REMSD; on other hand FOSB null
mice have less REMS (Shiromani et al., 2000). These changes
correlate with up regulation of early expressing genes upon total
sleep deprivation (Cirelli et al., 2004; Elliott et al., 2014). Nuclear
receptor co-repressor 2 (NCOR2), which is also known to be
silencing mediator of retinoid or thyroid-hormone receptors
(SMRT), was up regulated after REMSD. NCOR2 has been
suggested to be responsible for transcriptional regulation of
REMS and wakefulness (Millstein et al., 2011). NCOR2 recruits
histone deacetylase and regulates target gene expression by acting
as corepressor of many transcription factors. Also, peroxisome
proliferator-activated receptor gamma (PPARD) gene, which
is up regulated upon REMSD, interacts with NCORs and
regulates sleep (Millstein et al., 2011). FOXO3 belonging to the
forked head family of transcription factors, is up-regulated after
REMSD. Post-transcriptional modifications like acetylation and
methylation were increased after FOXO3 activity (Driver et al.,
2013). Thus, our findings support that disturbances in REMS
modulate epigenetic processes associated with chronic patho-
behavioral changes as proposed recently (Mehta et al., 2016).
Modulation of Gene Expression is Due to
REM Sleep Loss
We have compared relative expression of some neuropeptides,
histones and lncRNA after REM sleep deprivation as compared
to several control conditions like free moving control, large
platform control, recovery and Prazosin treated group. OXT,
LNPEP, AVP, GRIN2B, HCRT, HIST2H4 and RMRP were down
regulated as compared to free moving control and large platform
control; their expression returned to normal levels after 3 days
recovery. However, for HIST2H4 and GRIN2B genes, 3 days
recovery was not sufficient for complete recovery, which could
be due to many reasons including sensitivity, predisposition, and
necessity of more time for recovery. Several factors which were
affected upon REMSD returned to normal levels upon Prazosin
treatment. This suggests that the REMSD induced effects were
mediated by NA acting on alpha1 adrenoceptors and support
our contention. These factors were not affected if Prazosin
was injected to REMSD rats. However, RMRP and HCRT
gene expression were significantly increased in Prazosin treated
rats as compared to free moving control, REMSD and large
platform control rats; while GRIN2B gene expression reduced
after Prazosin treatment as compared to free moving control. It is
possible that expression of RMRP, HCRT and GRINB2B proteins
may play role(s) in modulating other functions in addition to
REMS.
Only a few studies had evaluated changes in transcriptome in
the total sleep deprived brain samples. However, as total sleep
deprivation includes REMSD as well as non-REMSD, it was
necessary to differentiate the effects of the two sleep deprivations
on brain transcriptome. As normally REMS does not appear
unless sufficient non-REMS has been expressed, it is practically
impossible to deprive animals exclusively of non-REMS (to
reasonable extent) without depriving them of complete REMS.
Thus, total sleep deprivation would have compounding as well
as confounding effects because it is difficult to design adequate
control experiments. Also, total sleep deprivation has cascading
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effects, which are more difficult to interpret. Therefore, in this
study we have deprived the rats of REMS in particular and
used NGS to evaluate the changes. For REMSD we used the
platform method, which is most effective as well as practical
choice and therefore, it has been extensively used across the globe
for unbiased long-term REMSD studies in animals (Gulyani et al.,
2000). Notwithstanding, like most experiments particularly for
in vivo behavioral studies, non-specific factor(s) affecting the
experimental REMSD rats on the smaller platform, also acted on
the large platform control and recovery control; thus the effects
were negated (Gulyani et al., 2000).
Although the whole transcriptome was analyzed on free
moving control and REMSD samples while a representative
set of genes were analyzed in large platform control, recovery
control and Prazosin treated group. The transcriptome data was
validated by carrying out qRT-PCR on DEGs (Figure 5). By
conducting large platform control, recovery control effect due
to movement restriction and hyperactivity by forced swimming
were neutralized, we have repeatedly shown that REMSD-
associated increased Na–K ATPase activity was due to REMSD
instead of other non-specific factors (Gulyani and Mallick,
1993, 1995; Gulyani et al., 2000; Mallick et al., 2002; Singh
et al., 2012). Therefore, as indirect evidence that the rats
were specifically deprived of REMS on small platform, in the
present study we estimated the Na–K ATPase activity as well as
ATP1B2 gene expression and they follow same trend. Further, the
REMSD-associated transcriptional changes showed proportional
expression after qRT-PCR analysis in the REMSD sample as
compared to large platform control and recovery control controls
confirming our contention (Figure 5). All the changes were
significant as compared to free moving control as well as large
platform control, which rule out effects due to non-specific
factors including stress. Additionally, as the changes returned or
tended to return to control levels in the recovery control rats, it
suggests that the effects were largely due to REMSD; however,
possibly more recovery time was required for those which did not
return to baseline after 3 days recovery. Although expression of
some of the genes changed in the large platform control samples
(as compared to free moving control), the changes in REMSD
samples were significant as compared to large platform control.
Notwithstanding, it is possible that expressions of some genes,
e.g., GRIN2B and HIST2H4 are more sensitive to some non-
specific exposure, which was not ruled out by the controls. The
changes in large platform control (as compared to free moving
control) could be due to marginal loss of non-REMS and/or
due to changes in other non-specific associated factors, which
although undesirable, sometimes is difficult to avoid or control
while conducting in vivo behavioral studies as REMSD.
It was important to differentiate between specific responses
induced by treatment, REMSD in this study, against non-specific
response due to stress. Therefore, it was necessary to conduct
appropriate control experiments. We carried out large platform
control and recovery control experiments, which were often
missing in earlier similar studies. Although elevated cortisol
(humans) or corticosterone (non-humans) has been considered
to signify stress, there are conflicting reports on their elevation
upon REMSD. In fact, many studies did not find REMSD-
associated significant elevation of cortisol in humans (Born et al.,
1988) or corticosterone in rats (Porkka-Heiskanen et al., 1995).
Besides, as Prazosin prevented or tended to prevent most of the
REMSD-associated effects, the effects were induced by NA, which
increases upon REMSD. Thus, the effects observed in this study
were due to REMSD and most unlikely due to stress or other
confounding factors.
CONCLUSION
Transcriptome analysis revealed that genes associated with
expression of NA, Na–K ATPase synthesis, synaptic potentiation,
chromatin, histone code and nuclear assembly and learning and
memory are differentially expressed in REMS deprived rat brain.
These modulations provide an underlying molecular genetic basis
for REMSD-associated physiological disturbances, neurological
conditions, reduced cognitive ability and reduced learning as well
as memory consolidation. Also, up-regulation of Na–K ATPase
activity, BMP4, DBH and SYT2 transcription offers a molecular
explanation for the sustained increase in neuronal excitability
upon REMSD and supports our hypothesis of role of REMS
in maintaining the excitability and house-keeping function of
the brain. Circumstantial evidence and control studies strongly
suggest that the effects were due to REMSD and unlikely due to
non-specific factors.
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